Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: Study CTRT99/97 by the Bronchial Carcinoma Therapy Group

Journal of Clinical Oncology

Volumn 24, Issue 27, 2006, Pages 4397-4404

  Huber, Rudolf M ^a   Flentje, Michael ^a   Schmidt, Michael ^a   Pöllinger, Barbara ^a   Gosse, Helga ^a   Willner, Jochen ^a   Ulm, Kurt ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ALLERGY; ANEMIA; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG DOSE REDUCTION; DYSPHAGIA; ESOPHAGITIS; FATIGUE; FEMALE; FEVER; FOLLOW UP; GASTRITIS; GRANULOCYTOPENIA; HAIR LOSS; HEART ARRHYTHMIA; HEMOPTYSIS; HUMAN; INFECTION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PAIN; PERIPHERAL NEUROPATHY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; SIDE EFFECT; SKIN TOXICITY; THROMBOCYTOPENIA; TREATMENT RESPONSE; WEIGHT REDUCTION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; DISEASE FREE SURVIVAL; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PHASE 3 CLINICAL TRIAL; REMISSION; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33749052914     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.4163     Document Type: Article

References (29)

1. Le Chevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small lung carcinoma. J Natl Cancer Inst 83:417-423, 1991
2. Dillman RO, Herndon J, Seagren SL, et al: Improved survival in stage III non-small-cell lung cancer: Seven year follow up of CALGB 8433 trial. J Natl Cancer Inst 88:1210-1215, 1966
3. Havemann K, Wolf M, Goerg C, et al: Paclitaxel and simultaneous radiation in the treatment of stage III A/B non-small cell lung cancer. Semin Oncol 22:19-22, 1995 (suppl 14)
4. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311:899-909, 1995
5. Clamon G, Herndon J, Cooper R, et al: Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17:4-11, 1999
6. Gatzemeier U, Heckmayer M, Neuhauss R, et al: Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: A phase II trial. Semin Oncol 22:24-28, 1995 (suppl 15)
7. Johnson DH, Chang AY, Ettinger DS: Taxol (paclitaxel) in the treatment of lung cancer: The Eastern Cooperative Oncology Group experience. Ann Oncol 5:S45-S50, 1994 (suppl 6)
8. Murphy WK, Fossella FV, Winn RJ, et al: Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 85:384-388, 1993
9. Bunn PA: The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Semin Oncol 23:18-25, 1996 (suppl 16)
10. Langer CJ, Millenson M, O'Dwyer P, et al: Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: A phase II study by the Fox Chase Cancer Center Network. Semin Oncol 23:35-41, 1996 (suppl 16)
11. Splinter TA: Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIa-N2) non small cell lung cancer. Semin Oncol 23:59-61, 1996 (suppl 16)
12. Choy H, Akerley W, Safran H, et al: Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J Clin Oncol 12:2682-2686, 1994
13. Willner J, Schmidt M, Kirschner J, et al: Sequential chemo- and radio-chemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer: Results of a dose escalation study. Lung Cancer 32:163-171, 2001
14. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced unresectable non-small-cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
15. Gervais R, Ducolone A, Lechevalier T, et al: Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatin (P)]: Final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer - Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT. J Clin Oncol 23: 625s, 2005 (suppl 16, abstr 7016)
16. Mote PA, Davey MW, Davey RA, et al: Paclitaxel sensitizes multidrug resistant cells to radiation. Anticancer Drugs 7:182-188, 1996
17. Geard CR, Jones JM, Schiff PB: Taxol and radiation. J Natl Cancer Inst Monogr 15:89-94, 1993
18. Leonard CE, Chan DC, Chou TC, et al: Paclitaxel enhances in vitro radio-sensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res 56:5198-5204, 1996
19. Vokes EE, Herndon JE 2nd, Crawford J, et al: Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and Leukemia Group B study 9431. J Clin Oncol 20:4191-4198, 2002
20. Belani CP, Choy H, Bonomi P, et al: Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23:5883-5891, 2005
21. Vokes EE, Herndon JE, Kelley MJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial. J Clin Oncol 22:618s, 2004 (suppl 14, abstr 7005)
22. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692-2699, 1999
23. Curran WJ, Scott CB, Langer CJ, et al: Long term benefit is observed in a phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 22:621, 2003 (abstr 2499)
24. Lau D, Leigh B, Gandara D, et al: Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/ paclitaxel consolidation for stage III non-small-cell lung cancer: A California Cancer Consortium phase II trial. J Clin Oncol 19:442-447, 2001
25. Movsas B, Scott C, Langer C, et al: Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group Trial 98-01. J Clin Oncol 23:2145-2154, 2005
26. Zatloukal P, Petruzelka L, Zemanova M, et al: Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study. Lung Cancer 46:87-98, 2004
27. Pierre F, Maurice P, Gilles R, et al: A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemoradiotherapy in locally advanced non-small cell lung cancer (GLOT-GFPC NPC 95-01). Proc Am Soc Clin Oncol 20:312a, 2001 (abstr 1246)
28. Zemanova M, Petruzelka L, Zemanova M, et al: Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer: A randomized phase II study. Proc Am Soc Clin Oncol 21:310a, 2002 (abstr 1159)
29. Gandara DR, Chansky K, Albain KS, et al: Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group Study S9504. J Clin Oncol 21:2004-2010, 2003